Speakers Speeches

December, 05th | 13:33 - 13:36
48 week results from the helios phase 1 trial evaluating intravitreal otx-tki for non-proliferative diabetic retinopathy
DHOOT DILSHER
Full program Add to calendar

December, 05th | 14:12 - 14:15
Robust vision gains and anatomical improvement with extended faricimab dosing and potential q20w dosing in treatment-naïve patients with NAMD in tenaya/lucerne
DHOOT DILSHER
Full program Add to calendar

December, 06th | 14:12 - 14:16
HELIOS: Phase 1 SAFETY Study of AXPAXLI in NPDR
DHOOT DILSHER
Full program Add to calendar

December, 06th | 11:17 - 11:24
Suprachoroidal ABBV-RGX-314 for Retinal Vascular Diseases
DHOOT DILSHER
Full program Add to calendar

December, 07th | 16:05 - 16:15
AXPAXLI for Treatment of DR: HELIOS Study
DHOOT DILSHER
Full program Add to calendar